D rug use and crime are undeniably linked. More than half of all adult arrestees test positive for drug use at the time of their apprehension. 1 Self-reports from prison inmates indicate that their drug use prior to incarceration is typically chronic and linked to other criminal behavior. Although only a fifth of inmates in State prisons in 1997 were incarcerated for drug crimes, 83 percent reported past drug use and 57 percent were using drugs in the month before their offense. 2 Despite their segregation from society and continuous close supervision, prison inmates still manage to obtain illicit drugs. Such drug use in prison threatens the safety of inmates and staff, contradicts rehabilitative goals, undermines the authority of the correctional institution, reduces public confidence, and ultimately corrodes the safety of communities and neighborhoods to which offenders return after prison.
Recognizing the Problem
In 1994 and again in 1998, as part of a national focus on violent crime, its link to drugs, and the pivotal role prisons can play in treating drug addiction, Congress took legislative steps to encourage States to implement comprehensive prison drug-testing and addiction treatment policies. 3 Even before the congressional impetus, however, Pennsylvania had acknowledged that drug use was pervasive in several of its prisons. Governor Tom Ridge appointed Martin F. Horn as secretary for corrections in 1995 and charged him with the responsibility of ridding the prison system of drugs.
Several prisons within the Pennsylvania Department of Corrections (PDC) system were suffering from widespread drug availability and use: Six inmates died of drug overdoses during 1995 and 1996, assaults on corrections officers and inmates had increased, and the press reported corruption among the staff and collusion between inmates and staff in obtaining drugs. The system's existing policies and resources were overwhelmed by the scope of the problem.
To rid Pennsylvania's prisons of drugs and to secure inmate and staff safety, Secretary Horn launched the Drug Interdiction Program, a broad-based strategy combining interdiction methods, drug testing, and drug treatment.
Secretary Horn also asked the National Institute of Justice (NIJ) to help assess the impact of the program in five prisons that represented a cross-section of the system. This article describes PDC's interdiction strategies, the evaluation effort, and the subsequent decrease in drug use.
Although Secretary Horn cites interdiction as the main reason for the decrease, he stresses that it alone does not account for the results. All inmates now undergo an evaluation to determine if they need substance abuse treatment when they enter the State's prison system. Nearly 92 percent do. All of Pennsylvania's 24 prisons offer treatment; 7 also operate therapeutic communities in which inmates with severe substance abuse problems are housed separately and undergo intensive, long-term treatment. In 1997, PDC opened its first substance abuse treatment prison, which requires inmates to undergo difficult, intensive, and long-term treatment.
PDC's Drug Interdiction Strategies
At the heart of PDC's comprehensive strategy was a zero-tolerance drug policy: Inmates caught with drugs were to be criminally prosecuted. Those testing positive in PDC's routine urine drug-testing program were to serve disciplinary custody time.
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The strategy relied on greater surveillance of both inmates and visitors, increased frequency of random urinalysis, more cell searches and surprise raids, and increased use of drugsniffing dogs.
PDC also introduced highly sensitive drug detection equipmention mobility spectrometers-to detect drugs that visitors might try to smuggle into the prison, to inspect packages arriving in the mail, and beginning in 1998, to detect drugs that correctional staff might try to bring into the prison.
In addition, new policies were issued for inmate movement and visitation, and new sanctions for drug violations were instituted. PDC also installed a new phone system, allowing staff to monitor inmates' calls on a random basis. Table 1 summarizes the major features of the Drug Interdiction Program put into place by PDC between 1995 and 1998.
Evaluating the Effects of the Program
PDC officials explored several options for measuring the impact of the Drug Interdiction Program and finally decided to measure drug use by adding hair testing to the urine testing already taking place.
Hair analysis is particularly suited to prison-based situations where drug use may be episodic and sporadic. Hair tests can reveal drug use that occurred anytime within the previous 90 days, whereas urinalysis is limited to detecting drug use within the previous 48 hours or so. 4 PDC officers collected hair and urine specimens from inmates on two occasions: in March 1996 (the first wave) and in February/ March 1998 (the second wave). They collected about 1,000 hair specimens from a random sample of male and female inmates at the five prisons. A head hair specimen was obtained whenever feasible, but axillary (chest or underarm) hair was accepted in those cases where sufficient head hair was unavailable. 5 (See sidebar "The Challenges of Hair Analysis," opposite)
Urine and hair specimens were collected at the same time. 6 To minimize the possibility of detecting drug use that had occurred prior to incarceration, only specimens from inmates who had been in the PDC system for at least 3 months were analyzed. The final sizes of the hair sample are shown in The Challenges of Hair Analysis
As they drew up their guidelines for using hair to test for drug use, PDC officials reviewed issues pertaining to inmate and correctional officer safety, hygiene, and religious restrictions on cutting hair. Guidelines pertaining to religious and other grounds for refusing the test were reviewed and implemented.
In accordance with accepted testing procedures, head hair was obtained whenever possible, but chest hair was accepted when an inmate's head hair was too short, shaved, or nonexistent.
In addition, PDC developed procedures for protecting the confidentiality of individual results from the hair drug tests because hair tests were to be used for research purposes only. Staff at NIJ compiled the statistical data and made aggregate reports available to PDC.
Corrections supervisors nominated officers to be trained in collecting, handling, and packaging the specimens.
Head Hair vs. Body Hair: Implications for Analysis
The proportion of body hair samples compared to head hair samples was greater than anticipated, particularly at two of the prisons. A hair specimen of about 60 to 80 strands was collected from each inmate. Each specimen was analyzed by Psychemedics Corporation in accordance with rigorous laboratory procedures. (Psychemedics received a contract from NIJ to conduct the analysis.) Before analysis, hair samples were trimmed to a standard length of 3.9 cm, representing the average rate of growth of head hair over a 3-month period. Some hair shorter than 3.9 cm was collected, and some longer hair was not trimmed to length because the root ends could not be properly aligned. Further sample preparation and analysis of the sample were conducted to resolve issues of potential environmental contamination.
cocaine. Two years later, posttest results showed that marijuana use had dropped to 0.3 percent and that 1.4 percent had used at least one illicit drug during the previous 90 days. Similar declines were realized for cocaine and opiates.
Hair samples were tested for evidence of use of marijuana, cocaine, opiates, amphetamines, and PCP. Radio-immunoassay (RIA)-a common drug-screening technique-was used to identify samples presumed to be positive; gas chromatography/mass spectrometry (GC/MS)-sometimes called the "gold standard" confirmatory testwas used to confirm the results. Urinalysis was performed according to standard laboratory immunoassay drug-screening procedures.
As table 3 shows, positive rates based on urinalysis were generally lower than rates based on head hair, and results based on head and body hair specimens were slightly higher than the results based on head hair only.
Drug Use by Inmate Characteristic and Offense Type
The first wave of drug tests done in 1996 provided sufficient variance in drug use to allow researchers to compare groups of inmates (see table 4 ), but by the second wave in 1998, the prevalence of positive drug tests was so low that similar comparisons could not be made. 
Implications for Communities
Because drug use in prisons erodes institutional authority and control, it also severely undermines the public's confidence in correctional institutions. It is disturbing to learn that inmates can continue drug consumption while serving their prison sentences.
Eliminating drugs in prisons is a crucial aspect of ensuring that prison order and safety are maintained, but perhaps most important, eliminating the problem ensures that inmates abstain from drugs during the time they serve their sentences-a necessary first step on the road to long-term abstinence with important implications for the time when inmates return home to their families and communities.
Notes
